Maternal mortality in six low and lower-middle income countries from 2010 to 2018: risk factors and trends.


Journal

Reproductive health
ISSN: 1742-4755
Titre abrégé: Reprod Health
Pays: England
ID NLM: 101224380

Informations de publication

Date de publication:
17 Dec 2020
Historique:
received: 28 08 2020
accepted: 02 09 2020
entrez: 18 12 2020
pubmed: 19 12 2020
medline: 16 6 2021
Statut: epublish

Résumé

Maternal mortality is a public health problem that disproportionately affects low and lower-middle income countries (LMICs). Appropriate data sources are lacking to effectively track maternal mortality and monitor changes in this health indicator over time. We analyzed data from women enrolled in the NICHD Global Network for Women's and Children's Health Research Maternal Newborn Health Registry (MNHR) from 2010 through 2018. Women delivering within research sites in the Democratic Republic of Congo, Guatemala, India (Nagpur and Belagavi), Kenya, Pakistan, and Zambia are included. We evaluated maternal and delivery characteristics using log-binomial models and multivariable models to obtain relative risk estimates for mortality. We used running averages to track maternal mortality ratio (MMR, maternal deaths per 100,000 live births) over time. We evaluated 571,321 pregnancies and 842 maternal deaths. We observed an MMR of 157 / 100,000 live births (95% CI 147, 167) across all sites, with a range of MMRs from 97 (76, 118) in the Guatemala site to 327 (293, 361) in the Pakistan site. When adjusted for maternal risk factors, risks of maternal mortality were higher with maternal age > 35 (RR 1.43 (1.06, 1.92)), no maternal education (RR 3.40 (2.08, 5.55)), lower education (RR 2.46 (1.54, 3.94)), nulliparity (RR 1.24 (1.01, 1.52)) and parity > 2 (RR 1.48 (1.15, 1.89)). Increased risk of maternal mortality was also associated with occurrence of obstructed labor (RR 1.58 (1.14, 2.19)), severe antepartum hemorrhage (RR 2.59 (1.83, 3.66)) and hypertensive disorders (RR 6.87 (5.05, 9.34)). Before and after adjusting for other characteristics, physician attendance at delivery, delivery in hospital and Caesarean delivery were associated with increased risk. We observed variable changes over time in the MMR within sites. The MNHR is a useful tool for tracking MMRs in these LMICs. We identified maternal and delivery characteristics associated with increased risk of death, some might be confounded by indication. Despite declines in MMR in some sites, all sites had an MMR higher than the Sustainable Development Goals target of below 70 per 100,000 live births by 2030. The MNHR is registered at NCT01073475 .

Sections du résumé

BACKGROUND BACKGROUND
Maternal mortality is a public health problem that disproportionately affects low and lower-middle income countries (LMICs). Appropriate data sources are lacking to effectively track maternal mortality and monitor changes in this health indicator over time.
METHODS METHODS
We analyzed data from women enrolled in the NICHD Global Network for Women's and Children's Health Research Maternal Newborn Health Registry (MNHR) from 2010 through 2018. Women delivering within research sites in the Democratic Republic of Congo, Guatemala, India (Nagpur and Belagavi), Kenya, Pakistan, and Zambia are included. We evaluated maternal and delivery characteristics using log-binomial models and multivariable models to obtain relative risk estimates for mortality. We used running averages to track maternal mortality ratio (MMR, maternal deaths per 100,000 live births) over time.
RESULTS RESULTS
We evaluated 571,321 pregnancies and 842 maternal deaths. We observed an MMR of 157 / 100,000 live births (95% CI 147, 167) across all sites, with a range of MMRs from 97 (76, 118) in the Guatemala site to 327 (293, 361) in the Pakistan site. When adjusted for maternal risk factors, risks of maternal mortality were higher with maternal age > 35 (RR 1.43 (1.06, 1.92)), no maternal education (RR 3.40 (2.08, 5.55)), lower education (RR 2.46 (1.54, 3.94)), nulliparity (RR 1.24 (1.01, 1.52)) and parity > 2 (RR 1.48 (1.15, 1.89)). Increased risk of maternal mortality was also associated with occurrence of obstructed labor (RR 1.58 (1.14, 2.19)), severe antepartum hemorrhage (RR 2.59 (1.83, 3.66)) and hypertensive disorders (RR 6.87 (5.05, 9.34)). Before and after adjusting for other characteristics, physician attendance at delivery, delivery in hospital and Caesarean delivery were associated with increased risk. We observed variable changes over time in the MMR within sites.
CONCLUSIONS CONCLUSIONS
The MNHR is a useful tool for tracking MMRs in these LMICs. We identified maternal and delivery characteristics associated with increased risk of death, some might be confounded by indication. Despite declines in MMR in some sites, all sites had an MMR higher than the Sustainable Development Goals target of below 70 per 100,000 live births by 2030.
TRIAL REGISTRATION BACKGROUND
The MNHR is registered at NCT01073475 .

Identifiants

pubmed: 33334343
doi: 10.1186/s12978-020-00990-z
pii: 10.1186/s12978-020-00990-z
pmc: PMC7745363
doi:

Banques de données

ClinicalTrials.gov
['NCT01073475']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

173

Subventions

Organisme : NICHD NIH HHS
ID : UG1 HD076461
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD078439
Pays : United States
Organisme : National Institute of Child Health and Human Development
ID : U10HD076465
Organisme : NICHD NIH HHS
ID : UG1 HD076465
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD076474
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD078438
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD076457
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD076474
Pays : United States

Références

Reprod Health. 2015;12 Suppl 2:S5
pubmed: 26062992
Lancet. 2006 Sep 30;368(9542):1189-200
pubmed: 17011946
Bull World Health Organ. 2016 Feb 1;94(2):155-6
pubmed: 26908966
Lancet. 2016 Oct 8;388(10053):1775-1812
pubmed: 27733286
Obstet Gynecol. 2018 Jan;131(1):138-142
pubmed: 29215526
Matern Health Neonatol Perinatol. 2017 Nov 7;3:19
pubmed: 29142757
Lancet. 2016 Oct 8;388(10053):1725-1774
pubmed: 27733285
Reprod Health. 2015;12 Suppl 2:S1
pubmed: 26063166
Int Perspect Sex Reprod Health. 2013 Mar;39(1):32-41
pubmed: 23584466
BMJ. 2018 Feb 15;360:k373
pubmed: 29449222
Global Health. 2015 Feb 12;11:4
pubmed: 25889910
Br Med Bull. 2017 Jan 1;121(1):121-134
pubmed: 28104630
BJOG. 2018 Aug;125(9):1137-1143
pubmed: 29094456
Stat Politics Policy. 2012 Jul 13;3(2):
pubmed: 24416714
Obstet Gynecol Clin North Am. 2018 Jun;45(2):175-186
pubmed: 29747724
Reprod Health. 2015;12 Suppl 2:S15
pubmed: 26062610
Lancet. 2016 Jan 30;387(10017):462-74
pubmed: 26584737

Auteurs

Melissa Bauserman (M)

Department of Pediatrics, University of North Carolina School of Medicine, 101 Manning Drive, CB 7596, Chapel Hill, NC, 27599-7596, USA. melissa_bauserman@med.unc.edu.

Vanessa R Thorsten (VR)

RTI International, Durham, NC, USA.

Tracy L Nolen (TL)

RTI International, Durham, NC, USA.

Jackie Patterson (J)

Department of Pediatrics, University of North Carolina School of Medicine, 101 Manning Drive, CB 7596, Chapel Hill, NC, 27599-7596, USA.

Adrien Lokangaka (A)

Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.

Antoinette Tshefu (A)

Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.

Archana B Patel (AB)

Lata Medical Research Foundation, Nagpur, India.
Adjunct Faculty Medical Research, Datta Meghe Institute of Medical Sciences, Sawangi, India.

Patricia L Hibberd (PL)

Boston University School of Public Health, Boston, MA, USA.

Ana L Garces (AL)

Instituto de Nutrición de Centroamérica y Panamá, Guatemala City, Guatemala.

Lester Figueroa (L)

Instituto de Nutrición de Centroamérica y Panamá, Guatemala City, Guatemala.

Nancy F Krebs (NF)

University of Colorado School of Medicine, Denver, CO, USA.

Fabian Esamai (F)

Moi University School of Medicine, Eldoret, Kenya.

Paul Nyongesa (P)

Moi University School of Medicine, Eldoret, Kenya.

Edward A Liechty (EA)

Indiana School of Medicine, University of Indiana, Indianapolis, IN, USA.

Waldemar A Carlo (WA)

University of Alabama at Birmingham, Birmingham, AL, USA.

Elwyn Chomba (E)

University Teaching Hospital, Lusaka, Zambia.

Shivaprasad S Goudar (SS)

KLE Academy Higher Education and Research, J N Medical College Belagavi, Belgaum, Karnataka, India.

Avinash Kavi (A)

KLE Academy Higher Education and Research, J N Medical College Belagavi, Belgaum, Karnataka, India.

Richard J Derman (RJ)

Thomas Jefferson University, Philadelphia, USA.

Sarah Saleem (S)

Aga Khan University, Karachi, Pakistan.

Saleem Jessani (S)

Aga Khan University, Karachi, Pakistan.

Sk Masum Billah (SM)

Maternal and Child Health Division (icddr, b), Dhaka, Bangladesh.
Sydney School of Public Health, The University of Sydney, Sydney, NSW, 2006, Australia.

Marion Koso-Thomas (M)

Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA.

Elizabeth M McClure (EM)

RTI International, Durham, NC, USA.

Robert L Goldenberg (RL)

Department of Obstetrics and Gynecology, Columbia University School of Medicine, New York, NY, USA.

Carl Bose (C)

Department of Pediatrics, University of North Carolina School of Medicine, 101 Manning Drive, CB 7596, Chapel Hill, NC, 27599-7596, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH